E2F1 and non-small cell lung carcinoma: In this scenario, E2F1-mediated repression of WNT5A expression promotes brain metastasis EGFR-mutant NSCLC, and high expression of E2F1 was negatively correlated with the expression of WNT5A and associated with poor outcomes in NSCLC [59].